南风轻轻，中药飘香。 2024年12月19日，习近平总书记在澳门科技大学考察时指出："中医药是中华文明的瑰宝，传承创新发 展中医药是件大事。要把这一祖先留给我们的宝贵财富继承好、发展好、利用好，推动中医药走向世 界。" 2018年10月22日，习近平总书记考察珠海横琴新区粤澳合作中医药科技产业园时强调："中医药学是中 华文明的瑰宝。要深入发掘中医药宝库中的精华，推进产学研一体化，推进中医药产业化、现代化，让 中医药走向世界。" 从一只蜂看中医特色 冰箱里堆满"调料包"，厨房就是"中药房"，一年四季都在吃药膳、煲靓汤、喝凉茶。在广东，几乎人人 都能说出一两个养生药方。木棉花开时节，当地人喜欢捡拾掉落的木棉花朵，洗净晒干之后煲汤，清热 祛湿。广东省卫生健康委副主任、省中医药局局长邱亚洪说："信中医、爱中医、用中医，成为广东人 的生活方式。" 数据来源：广东省中医药管理局等 2024年，广东省医疗卫生机构的中医诊疗量达2.52亿人次，占全省总诊疗量的26.2%。其中，广东省中 医院（广州中医药大学第二附属医院）年服务患者量连续20多年位居全国中医院之首。 蜜蜂一蜇，就能治病？这不是武侠小说里的情节，而是一种古老的中 ...

Group 1: Core Insights - Traditional Chinese medicine (TCM) is emphasized as a valuable heritage of Chinese civilization, with a strong push for its innovation and global promotion [1][2] - Guangdong province has implemented significant measures to promote the inheritance and innovation of TCM, aiming to establish a comprehensive reform demonstration zone for TCM [1] - The TCM industry in Guangdong is experiencing rapid growth, with the total annual output value exceeding 60 billion yuan, making it a leading region in China's TCM market [10] Group 2: TCM Practices and Innovations - In Guangdong, TCM practices are deeply integrated into daily life, with a reported 2.52 billion TCM consultations in 2024, accounting for 26.2% of total medical consultations in the province [2] - Innovative therapies such as bee therapy, which combines acupuncture and apitherapy, are gaining traction, showing significant clinical efficacy for various conditions [4] - The Guangdong Provincial Hospital of Traditional Chinese Medicine has introduced a "smart pharmacy" service, enhancing the efficiency and quality of TCM prescriptions through technology [6][7] Group 3: Talent Development and Education - The "master-apprentice" model is a key approach for cultivating TCM talent, with over 205 mentors, including 47 national TCM masters, involved in training [6] - Guangdong province is focusing on a comprehensive evaluation system for TCM practitioners, emphasizing practical abilities in diagnosis and treatment [6] Group 4: Internationalization and Market Expansion - The Guangdong-Macao Traditional Chinese Medicine Technology Industrial Park serves as a strategic hub for the internationalization of TCM, facilitating product registration and market entry in Portuguese-speaking countries [15][17] - Successful examples of TCM products entering international markets include the "Hua Tuo Rejuvenation Pill," which has gained recognition in Russia and other regions [18] Group 5: Research and Development - The Guangdong Provincial Laboratory for TCM is advancing research and development, focusing on innovative diagnostic technologies and the integration of AI in TCM practices [16] - The modern TCM industry in Guangdong is supported by a robust network of research institutions and universities, fostering collaboration and innovation [11]

济川煎颗粒处方来源于明朝张景岳《景岳全书》，已列入《古代经典名方目录（第一批）》，具有温肾 益精、润肠通便的功效，适用于肾虚便秘证。在该品种研发申报过程中，省药监局将其纳入创新药品服 务清单，实行三级联动服务机制，"一品一策"跟踪帮扶，精准破解药材基原把控、生产工艺优化、质量 标准建立等关键难题，助力产品顺利获批。 近日，合肥华润神鹿药业有限公司持有的古代经典名方制剂济川煎颗粒获批上市。该品种是2024年以来 我省继芍药甘草汤颗粒、半夏白术天麻汤颗粒之后第三个获批的经典名方新药，标志着我省在经典名方 传承创新转化领域迎来密集收获期。 作为省药监局推行"监督+服务"一体化模式的生动实践，多个古代经典名方制剂的顺利获批，为我省后 续中药新药转化提供了可复制、可推广的经验范本。下一步，省药监局将持续聚焦中医药传承创新发 展，健全经典名方研发转化长效机制，加大对中药创新企业的政策支持与技术指导力度，以监管服务赋 能中药产业高质量发展。 （来源：市场星报） ...

Group 1 - The core viewpoint of the article is the announcement of pilot regions for Traditional Chinese Medicine (TCM) payment by disease, with Wuhu City in Anhui Province being selected as one of the nine pilot cities nationwide [1] - This pilot program is part of the national effort to reform medical insurance payment methods and support the inheritance and innovation of TCM [1] - Wuhu will build on previous experiences with TCM payment practices to refine implementation plans and promote the pilot program steadily, aiming to explore replicable and scalable TCM medical insurance payment experiences [1] Group 2 - The initiative aims to better leverage the unique characteristics of TCM, which are described as "simple, effective, and economical," to benefit a larger number of insured individuals [1]

Core Viewpoint - Guangxi aims to accelerate the construction of a high-quality and efficient traditional Chinese medicine (TCM) service system, ensuring that the benefits of TCM development are more equitable and fully accessible to the public [1][2]. Group 1: Development Initiatives - Guangxi will continue to promote the construction of TCM departments and professional teams in general hospitals, expanding TCM specialty techniques into non-TCM clinical departments [1]. - The region will strengthen the training of talents in "Western learning of Chinese medicine," expanding clinical pathways that integrate both Western and Chinese medicine [2]. - A focus will be placed on the health management of the elderly and children, enhancing the diagnostic and treatment capabilities of grassroots TCM services [2]. Group 2: Infrastructure and Capacity Building - The construction of county-level TCM hospitals will be advanced, emphasizing the development of flagship TCM clinics and centers [2]. - Guangxi will implement pilot projects for chronic disease management in TCM, encouraging county-level hospitals to lead the establishment of chronic disease management centers [2]. - The region will enhance the capabilities of TCM nursing and conduct selections for "Top Ten TCM Nursing Clinics," exploring TCM prevention and treatment for childhood obesity and scoliosis [2]. Group 3: Policy and Growth Metrics - Since the 14th Five-Year Plan, the development of TCM (including Zhuang and Yao medicine) in Guangxi has shown significant progress, with a 35.2% increase in TCM medical institutions, totaling 2,886 [3]. - The number of TCM hospitals has reached 150, with 1,441 grassroots TCM clinics established, including 152 flagship clinics and 134 TCM pavilions, significantly improving the accessibility of grassroots TCM services [3].

Core Insights - The Yantai Maternal and Child Health Hospital's "Yao Jihong Traditional Chinese Medicine Inheritance Studio" has been recognized as a national project, marking a significant achievement in the field of maternal and child healthcare [1] - This initiative aligns with the strategic deployment of traditional Chinese medicine (TCM) inheritance and innovation, positioning Yantai's maternal and child TCM efforts among the leading ranks in the country [1] Group 1 - The project is a key measure to implement the major strategic deployment of TCM inheritance and innovation [1] - Yantai Maternal and Child Health Hospital is the only selected unit from Yantai City, highlighting its unique position in the national landscape of maternal and child TCM [1] - The hospital's TCM department is a key specialty in Yantai, with a strong professional structure and technical capabilities, providing a solid foundation for the "Inheritance Studio" [1] Group 2 - The "Inheritance Studio" will focus on four core tasks: systematic organization of Yao Jihong's academic thoughts, cultivation of a high-level inheritance team, research innovation and achievement transformation, and intelligent development pathways [1] - The studio aims to enhance TCM services for women and children throughout their life cycle, including pre-marital conditioning, prenatal care, postpartum recovery, and newborn care [2] - The initiative will strengthen the talent pipeline in maternal and child TCM, fostering young and middle-aged backbone forces to ensure the transmission of academic thoughts and clinical experiences from renowned TCM experts [2]

近日，"大批中成药将退出市场"的话题登上热搜，引发公众广泛关切。中药行业是否会迎来"大洗牌"？患者日常用药又是否会受影响？ 实际上，这一讨论的核心来源于国家药监局2023年7月1日施行的《中药注册管理专门规定》(以下简称《规定》)。其中明确要求，2026年7月1日起，中成 药说明书中若"禁忌""不良反应""注意事项"任何一项仍标注"尚不明确"，将不予再注册，无法继续上市销售。 但"退市倒计时"真的迫在眉睫吗？《规定》已为行业留出充足缓冲期——政策实施设有3年过渡期，再加上药品再注册周期为5年，这意味着企业实际可用 的调整时间最长可达8年。多数产品距离最终时限仍有一段关键准备期。 推动说明书从"尚不明确"走向"清晰透明"，是中药科学化、规范化发展的必然一步。国家药监局近年已发布多项指导原则，并持续推进相关修订工作。数 据显示，近两年绝大多数中药品种已完成本轮再注册，行业整体正稳步向更安全、更可溯源的现代化阶段迈进。 中国中药协会2月2日发布的《关于共同维护产业高质量发展环境的呼吁函》指出，当前网络流传的部分解读存在数据误用、误导公众之嫌。文件强调，该 《规定》旨在遵循中医药规律，加强中药新药研制与注册管理，推动 ...

云南省政协第十三届委员会第四次会议和第十四届人民代表大会第四次会议在海埂会堂相继开幕。来自全省各条战线的人大代表和政协委员齐聚一堂，共 商发展大计，共绘云南高质量发展新蓝图。全国政协委员、一心堂药业集团董事长阮鸿献，省政协委员、一心堂药业集团副总裁阮国伟参会，积极履行委 员职责，围绕生物医药产业发展、中医药传承创新、医保支付改革、民生健康服务等关键领域提交多项提案，积极建言献策。 阮鸿献委员表示，真切感受"自己人"的温暖与信赖。近年来，云南省委、省政府持续优化营商环境，出台了一系列务实举措，真心实意支持民营经济发 展，深刻感受到了"把民营企业家当作自己人"的鲜明态度和温暖氛围，这让扎根云南、深耕发展的信心更加坚定。这种尊商、重商、亲商、安商的环境， 为民营企业大胆创新、放心投资提供了坚实后盾，也激励着广大企业家更积极地回馈社会、担当责任。将一如既往地聚焦国计民生、产业发展，充分发挥 委员作用，将企业的行业实践与政策建言紧密结合，为推动云南经济社会高质量跨越式发展贡献更多智慧和力量。 云南省第十四届人民代表大会第四次会议 取协云南省第十三届委员会第四次会议 HINDOCALLE (NE) e 代表大会强烈大会议 ...

构建体系化的研发矩阵。不久前，随着石碧院士、陈卫院士双院士工作站落地东阿阿胶，一场围绕阿胶 的现代科学解析加速展开。从阿胶原料的标准化研究到大健康领域的深度研究，传统中药的密码，正被 一步步破译。这不仅是两个院士工作站的落地，更是一个立体化创新体系逐渐成型的缩影——东阿阿胶 将其称为"一中心三高地+N联合"研发创新体系。以获批的国家胶类中药工程技术研究中心为核心，打 造"原料涵养研发高地"、"滋补中药研发高地"、"健康消费品研发高地"。同时，与中国农业大学、四川 大学、江南大学、中国科学院大连化学物理研究所等超过40所高校和科研院所展开深度合作，形成了强 大的创新网络。 中医药学是中华民族的伟大创造，是中国古代科学的瑰宝。推动中医药传承创新发展，是时代赋予的命 题。国务院办公厅印发的《关于提升中药质量促进中医药产业高质量发展的意见》明确提出，要加快推 进中药产业转型升级。 面对新的发展要求，传统中药企业如何破局而立，向"新"而行? 以东阿阿胶股份有限公司(以下简称"东阿阿胶")为代表的一批老字号企业，正以生动的实践作答。根据 东阿阿胶年报，其营业收入从2021年的38.49亿元稳健增长至2024年的59.21 ...

科技赋能为成长"睛"彩护航！"AI时代的少年儿童眼健康守护行动"暨"爱阅读 爱眼睛 AI接千万家"系列活动在京启动 未来网北京1月31日电（记者 凌萌）1月30日，"AI时代的少年儿童眼健康守护行动"暨"爱阅读 爱眼睛 AI接千万家"系列活动在京正式启动。本次活动由中国 少年儿童新闻出版总社、中山大学中山眼科中心、中国中医科学院眼科医院联合主办，未来网承办，凝聚政府、学术、医疗、出版及科技领域的多方力量， 旨在深入推进青少年阅读、眼健康和人工智能科技的融合发展，为儿童青少年的全面成长提供更科学、更温暖的守护。 启动仪式在童真洋溢的儿童朗诵表演中拉开帷幕，孩子们用清澈的童音传递着对健康视力与美好未来的向往。 在人工智能技术快速发展、阅读场景日益多元的当下，儿童青少年近视问题日益凸显，成为影响儿童青少年身心健康发展的重大公共卫生问题。中国少年儿 童新闻出版总社党委书记、董事长曾锐在致辞中指出，作为少儿出版领域的"国家队"，中国少年儿童新闻出版总社立足70余年专业积淀，积极从传统内容出 版方向"教育服务者""少年新闻社""品牌运营方"转型，全力构建少儿阅读融合生态。此次联合专业眼科医院发起的眼健康守护行动，将联合多 ...